Guideline: Page 3

Mercy Research to offer Grail multicancer blood test
By LabPulse.com staff writers
The test, which aims to complement U.S. guideline-recommended cancer screenings, looks for a shared signal present in the bloodstream that has been associated with many cancers.
July 12, 2022
2021 04 19 16 59 1236 Fingerprick Blood 400
Exact Sciences supports CMS screening policy changes
By LabPulse.com staff writers
The CMS Calendar Year 2023 Physician Fee Schedule proposal considers follow-up colonoscopy to an at-home test as a preventative service. The rule would eliminate all costs to Medicare patients for a follow-up colonoscopy following a positive at-home colorectal cancer screening test.
July 10, 2022
2019 09 23 17 18 0797 Colon Intestine 400
Fountain Health Insurance to cover Grail multicancer test
By LabPulse.com staff writers
In a clinical study, the Galleri test demonstrated that it detects a shared signal from more than 50 types of cancers. More than 45 of them currently lack recommended screening tests, the firms noted.
June 21, 2022
2021 06 07 23 26 6198 Blood Tube Tumor Marker Test 400
Study: less than half of pregnant people screened for HCV
By LabPulse.com staff writers
Quest noted that the CDC and the U.S. Preventive Services Task Force (USPSTF) published guidelines in early 2020 acknowledging the value of HCV antibody screening in response to growing rates of infection. A significant increase in screening was seen following the guidelines but many patients are still not receiving the recommended testing, Quest noted.
June 12, 2022
2020 03 03 23 13 0226 Hepatitis C Virus 400
ASCO presentation highlights clinical utility of ctDNA testing
By Leo O'Connor
Findings from the study were presented Saturday at the annual meeting of the American Society of Clinical Oncology and published in the New England Journal of Medicine.
June 5, 2022
2020 01 08 00 29 4037 Colon Cancer 400
Labcorp launches skin cancer assay
By LabPulse.com staff writers
Studies have shown that LAG-3 is an immune-oncology target with demonstrable clinical benefit in patients with melanoma. Labcorp said its LAG-3 IHC method has demonstrated performance suitable for analysis of LAG-3 immune cell expression in clinical melanoma samples in a study published May 9 in the Journal of Clinical Pathology.
May 18, 2022
2021 02 22 22 44 5518 Lab Doctors Dna 400
Diadem highlights new study on AlzoSure test for Alzheimer's
By LabPulse.com staff writers
In a retrospective study published online May 17 in the Journal of Prevention of Alzheimer's Disease, researchers reported that AlzoSure Predict achieved an area under the curve (AUC) of more than 0.98 for identifying people who would progress to future symptomatic Alzheimer's disease up to six years before diagnosis.
May 17, 2022
2019 07 15 19 08 6013 Amyloid Plaque Alzheimer 400
Dalrada Health completes cervical cancer screening kit trial
By LabPulse.com staff writers
Results from the trial were published this month in the Indian Society of Perinatology and Reproductive Biology (IJOPARB) journal. Study participants were screened for cervical cancer with cerVIA, which showed an accuracy of 91%, according to the firm. The test is patent-pending, Dalrada said.
April 24, 2022
2019 11 07 23 47 6944 Squamous Epithelial Cells Cervical 400
Lucid promotes new guideline from ACG on esophageal cancer
By LabPulse.com staff writers
The new guidelines include a reference to screening for esophageal cancer using Lucid's EsoGuard DNA test on samples collected with its EsoCheck Cell Collection device, it said.
April 3, 2022
2019 04 05 16 58 5171 Cancer Cell 400
Guardant to highlight cancer screening studies at AACR
By LabPulse.com staff writers
Key presentations will include data from Guardant's multicancer screening assay, Guardant Shield.
March 9, 2022
2020 06 01 18 51 2022 Cancer Lung 400
Article supports FDA review of lab-developed tests
By Kate Madden Yee
The U.S. Department of Health and Human Services (HHS) in August 2020 ruled that LDTs to diagnose whether patients are infected with SARS-CoV-2 did not have to undergo review by the FDA.
March 7, 2022
2019 05 15 20 52 2340 Lab Pcr Tubes Dna 400
AI of chest x-rays finds TB when lab tests fall short
By Leah Sherwood and Erik L. Ridley
As part of the End TB strategy, the World Health Organization (WHO) has recommended the use of chest x-ray as a screening and triage tool where bacteriological diagnostic tests are unclear. Inconclusive TB tests are common in children due to their lower bacteria counts, according to the WHO. The strategy also states that lateral chest x-ray views may be needed in cases of a challenging bacteriological confirmation in younger children.
March 6, 2022
2020 01 17 20 32 8969 Bacteria Mycobacterium Tuberculosis 400
Previous Page
Page 3 of 9
Next Page